Cardiometabolic Effects of Dipeptidyl Peptidase IV and Related Pathways
Enrolling By Invitation
18-99 years
All
Phase
N/A
32 participants needed
1 Location
Brief description of study
DPP4 is an enzyme that breaks down proteins that may affect blood sugar and the heart. We will recruit individuals from the Penn Biobank (cases, controls). Participants will be asked to complete a meal test, DXA, and echocardiogram with exercise. A cardiac MRI and related pilot study are optional.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: heart,cardio,cardiology
-
Age: Between 18 Years - 99 Years
-
Gender: All
Updated on
01 Aug 2024.
Study ID: 834482
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com
